Topical Treatment for Hidradenitis Suppurativa in Breastfeeding Patients
Use topical clindamycin 1% solution as your first-line topical antibiotic, combined with antiseptic washes such as chlorhexidine or benzoyl peroxide. These agents can be used with the same approach as in other HS populations during breastfeeding 1.
Recommended Topical Approach
The 2025 North American guidelines specifically address breastfeeding patients with HS and provide clear direction for topical management:
First-Line Topical Antibiotics
- Topical clindamycin 1% is the only topical antibiotic with clinical trial evidence in HS 2
- Apply with an approach similar to other HS patient populations during breastfeeding 1
- Minimal systemic absorption makes topical formulations safe during lactation
Antiseptic Washes (Use Concomitantly)
The guidelines recommend combining topical antibiotics with antiseptic washes to reduce bacterial resistance 1. Safe options include:
- Chlorhexidine - unlikely to pose risks during breastfeeding based on mechanism of action 1
- Benzoyl peroxide - supported by expert opinion 2
- Zinc pyrithione - unlikely to pose risks during breastfeeding 1
- Bleach baths - unlikely to pose risks during breastfeeding 1
Additional Topical Options
- Resorcinol 15% cream - keratolytic and antiseptic agent studied in Hurley stage I-II disease 2
- Reduces pain and duration of abscesses
- Caution: Irritant dermatitis is frequent; no specific breastfeeding safety data in guidelines
Important Clinical Considerations
What to Avoid
- Triclosan should be avoided during pregnancy due to potential endocrine-disrupting effects 1; apply similar caution during breastfeeding
Systemic Absorption Concerns
Topical therapies have minimal systemic absorption, making them inherently safer during breastfeeding than systemic medications. The guidelines do not raise specific concerns about topical clindamycin during lactation, unlike oral clindamycin which may increase GI side effects in infants 1.
Practical Algorithm
- Start with topical clindamycin 1% solution twice daily to affected areas
- Add daily antiseptic wash (chlorhexidine or benzoyl peroxide preferred)
- For acute localized flares, consider intralesional corticosteroids as an adjunct 1
- If inadequate response after 12 weeks, escalate to systemic therapy while continuing topical management
Evidence Quality Note
The recommendations for topical antibiotics in breastfeeding patients carry conditional strength with very low quality evidence 1, reflecting extrapolation from general HS populations and pharmacokinetic principles rather than dedicated breastfeeding studies. However, the favorable safety profile of topical agents with minimal systemic absorption supports their use as first-line therapy.
The 2025 guidelines represent the most current North American consensus specifically addressing special populations including breastfeeding patients 1, superseding the 2019 general management guidelines 2.